SynthesisBMC pregnancy and childbirth2026
Effects of antenatal breast milk expression on maternal and infant outcomes: a systematic review and meta-analysis.
Synthesis in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAntenatal breast milk expression (ABME) is a potential strategy to promote breastfeeding, but its clinical safety and efficacy remain unclear.
objectiveThe study aims to systematically evaluate the impact of ABME on breastfeeding, maternal, and neonatal outcomes.
methodsEleven electronic databases were searched from inception to January 14, 2026, to identify randomized controlled trials (RCTs) investigating ABME. Study quality was assessed using the Cochrane Risk of Bias tool. Heterogeneity was evaluated using the I
resultsA total of 3,077 studies were identified. After the removal of duplicates and selection, eleven RCTs studies involving 1,571 women met the inclusion criteria and eight studies were included in the meta-analysis. Compared to the standard care group, women who performed ABME have a lower risk of DOL II in the postpartum period (odds ratio [OR]: 0.30; 95% CI: 0.16-0.56; I
conclusionABME effectively reduces the incidence of DOL II and supports early exclusive breastfeeding without compromising maternal or neonatal safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.